During the past decade, Provident Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Provident Clinical Research" #1 sponsor was "Midwest Center for Metabolic and Cardiovascular Research" with 6 trials, followed by "Abbott Nutrition" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "ChromaDex, Inc." with 1 trials sponsored and "DSM Nutritional Products, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Provident Clinical Research" #1 collaborator was "ACH Food Companies, Inc." with 1 trials as a collaborator, "Almond Board of California" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Great Lakes Drug Development, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Provident Clinical Research" are "Cognitive Function" (2 trials), "PreDiabetes" (2 trials), "Alertness" (1 trials), "Attention" (1 trials) and "Bioavailability" (1 trials). Many other conditions were trialed in "Provident Clinical Research" in a lesser frequency.

Most popular intervention types in "Provident Clinical Research" are "Other" (8 trials), "Dietary Supplement" (6 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "1.5 oz of whole, natural almonds" (1 trials), "1000 mg/day of TRU NIAGEN (nicotinamide riboside)" (1 trials), "300 mg/day of TRU NIAGEN (nicotinamide riboside)" (1 trials) and "300 mg/day of dietary supplement containing carrageenan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Provident Clinical Research" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Provident Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Provident Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Provident Clinical Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".